Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues

David G McLeod; Paul F Schellhammer; Nicholas J Vogelzang; Mark S Soloway; Rooholloh Sharifi; Norman L Block; Peter M Venner; A. Lynn Patterson; Michael F Sarosdy; R. Patrick Kelley; Geert J.C.M Kolvenbag; Casodex Combination Study Grp

doi:10.1002/(SICI)1097-0045(19990901)40:4<218::AID-PROS2>3.0.CO;2-6

Back

Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues

Journal article

Peer reviewed

Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues

David G McLeod, Paul F Schellhammer, Nicholas J Vogelzang, Mark S Soloway, Rooholloh Sharifi, Norman L Block, Peter M Venner, A. Lynn Patterson, Michael F Sarosdy, R. Patrick Kelley, …

The Prostate, Vol.40(4), pp.218-224

1999-09-01

DOI: https://doi.org/10.1002/(SICI)1097-0045(19990901)40:4<218::AID-PROS2>3.0.CO;2-6

PMID: 10420149

Abstract

bicalutamide

clinical outcome

combined androgen blockade

flutamide

racial differences

Metrics

9 Record Views

16 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.147 Prostate Cancer; 1.147.97 Prostate Cancer
Web Of Science research areas: Endocrinology & Metabolism; Urology & Nephrology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues
Creators: David G McLeod - Urology Service, Walter Reed Army Medical Center, Washington, DC
Paul F Schellhammer - Eastern Virginia Medical School, Norfolk, Virginia
Nicholas J Vogelzang - University of Chicago Medical Center, Chicago, Illinois
Mark S Soloway - Department of Urology, University of Miami School of Medicine, Miami, Florida
Rooholloh Sharifi - University of Chicago Medical Center, Chicago, Illinois
Norman L Block - Department of Urology, University of Miami School of Medicine, Miami, Florida
Peter M Venner - Cross Cancer Institute, Edmonton, Alberta, Canada
A. Lynn Patterson - Department of Urology, University of Tennessee-Memphis, Memphis, Tennessee
Michael F Sarosdy - Division of Urology, University of Texas Health Science Center, San Antonio, Texas
R. Patrick Kelley - Zeneca Pharmaceuticals, Wilmington, Delaware
Geert J.C.M Kolvenbag - Zeneca Pharmaceuticals, Wilmington, Delaware
Casodex Combination Study Grp
Publication Details: The Prostate, Vol.40(4), pp.218-224
Publisher: John Wiley & Sons, Inc
Number of pages: 7
Academic Unit: UMMG Department of Pathology
Language: English
Resource Type: Journal article
PMID: 10420149
Record Identifier: 991031613513902976